Adult ID

Pediatric ID

Oral Abstract

34 - Viral Infections - Host, Pathogen, and Impact of Intervention

Presentations:

• 10:30 AM - 10:42 AM

  92 - Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2019
  Angela Branche, MD – University of Rochester; Lisa Saiman, MD, MPH – Columbia University Irving Medical Center; Edward E. Walsh, MD – University of Rochester; Ann R. Falsey, MD – University of Rochester; William Sieling, MPH – Columbia University Irving Medical Center; Matthew Oberhardt, PhD – NewYork-Presbyterian Hospital; Philip Zachariah, MD, MSc – Columbia University Irving Medical Center/ NewYork Presbyterian Hospital; William G. Greendyke, MD – Columbia University Irving Medical Center; Angela Barrett, BA – Columbia University Irving Medical Center; Celibell Vargas, MD – Columbia University Irving Medical Center; Luis Alba, B.S. – Columbia University Irving Medical Center; Matthew R. Phillips, MPH – Merck & Co., Inc.; Lyn Finelli, DrPH, MS – Merck & Co., Inc.
• 10:42 AM - 10:55 AM

  93 - Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination — United States, 2000-2018
  Benjamin D. Hallowell, PhD, MPH – Division of Viral Diseases, Centers for Disease Control and Prevention; Umesh D. Parashar, MD – Division of Viral Diseases, Centers for Disease Control and Prevention; Aaron Curns, MPH – Division of Viral Diseases, Centers for Disease Control and Prevention; Nicholas DeGroote, MPH – Division of Viral Diseases, Centers for Disease Control and Prevention; Jacqueline Tate, PhD – Division of Viral Diseases, Centers for Disease Control and Prevention
• 10:55 AM - 11:07 AM

  94 - Pneumonia Severity Scores Poorly Predict Severe Outcomes Among Adults Hospitalized with Influenza.
  Joshua Doyle, MD, PhD – Centers for Disease Control and Prevention; Shikha Garg, MD, MPH – CDC; Alissa O'Halloran, MSPH – CDC; Lauren Beacham, MA – Centers for Disease Control and Prevention; Charisse N. Cummings, MPH – CDC; Rachel Herlihy, MD. MPH – Colorado Department of Public Health and Environment; Kim Yousey-Hindes, MPH, CPH – Connecticut Emerging Infections Program; Evan J. Anderson, MD – Emory University, Atlanta VA Medical Center; Maya Monroe, MPH – Maryland Department of Health and Mental Hygiene; Sue Kim, MPH – Michigan Department of Health and Human Services; Ruth Lynfield, MD – Minnesota Department of Health; Lourdes Irizarry, MD – New Mexico Department of Health; Nancy Spina, MPH – New York State Department of Health; Nancy M. Bennett, MD – University of Rochester School of Medicine and Dentistry; Mary Hill, MPH – Salt Lake County Health Department; Carrie Reed, DSc, MPH – CDC; William Schaffner, MD – Vanderbilt University Medical Center; Keipp Talbot, MD, MPH – Vanderbilt University Medical Center; Wesley Self, MD, MPH – Vanderbilt University Medical Center; Derek Williams, MD, MPH – Vanderbilt University Medical Center
• 11:07 AM - 11:19 AM

  95 - Impact of Influenza-Like Illnesses on Academic and Work Performance on a College Campus
  Anne Emanuels, MPH – University of Washington; Elisabeth Brandstetter, MPH – University of Washington; Kira L. Newman, MD, PhD – University of Washington; Caitlin R. Wolf, BA – University of Washington; Jennifer Logue, BS – University of Washington; Janet A. Englund, MD – Seattle Children's Hospital/Univ. of Washington; Michael Boeckh, MD PhD – Fred Hutchinson Cancer Research Center; Helen Y. Chu, MD MPH – University of Washington
• 11:19 AM - 11:31 AM

  96 - Human Papilloma Viruses associated diseases in a cohort of patients with Idiopathic CD4 Lymphopenia
  Harry Mystakelis, MD – National Institute of Allergy and Infectious Diseases; Elizabeth Laidlaw, PA – National Institute of Allergy and Infectious Diseases; Megan Anderson, RN – National Institutes of Health; Peiying Ye, PhD – National Institutes of Health; Maura Manion, MD – Division of Clinical Research, NIAID; Isaac Brownell, MD/PHD – National Institute of Arthritis and Musculoskeletal and Skin Diseases; Irini Sereti, M.D. – Laboratory of Immunoregulation, NIAID; Andrea Lisco, MD/PHD – National Institute of Allergy and Infectious Diseases
• 11:31 AM - 11:43 AM

  97 - Competition Experiments for the Baloxavir-Resistant I38T Influenza A Mutant
  Guy Boivin, MD – Centre Hospitalier Universitaire de Québec, Québec, Québec; Liva Checkmahomed, Msc – Université Laval; Zeineb Mhamdi, Msc – Université Laval; Julie Carbonneau, Msc – Université Laval; Mariana Baz, PhD – Université Laval; Yacine Abed, PhD – Université Laval

Co-Author(s)

• EB

  Elisabeth Brandstetter, MPH

  Research Coordinator
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• LC

  Liva Checkmahomed, Msc

  CHU de Quebec
  Université Laval
  Quebec, QC, Canada

  Disclosure: Nothing to disclose
• SG

  Shikha Garg, MD, MPH

  Medical Epidemiologist
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• EL

  Elizabeth Laidlaw, PA

  Physician's Assistant
  National Institute of Allergy and Infectious Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose
• UP

  Umesh Parashar, MD

  Medical Officer
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• LS

  Lisa Saiman, MD, MPH

  Professor of Pediatrics
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Nothing to disclose
• MA

  Megan Anderson, RN

  RN
  National Institutes of Health
  Bethesda, MD

  Disclosure: Nothing to disclose
• AC

  Aaron Curns, MPH

  Lead Epidemiologist
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• ZM

  Zeineb Mhamdi, Msc

  CHU de Quebec
  Université Laval
  Quebec, QC, Canada

  Disclosure: Nothing to disclose
• KN

  Kira Newman, MD, PhD

  Resident Physician
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• AO

  Alissa O'Halloran, MSPH

  Epidemiologist
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• 

  Edward Walsh, MD

  Professor of Medicine
  University of Rochester
  Rochester, New York

  Disclosure: Janssen Pharm: Consultant, no financial payment however
  Pfizer: Research Grant
• LB

  Lauren Beacham, MA

  Statistician
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• JC

  Julie Carbonneau, Msc

  CHU de Quebec
  Université Laval
  Quebec, QC, Canada

  Disclosure: Nothing to disclose
• ND

  Nicholas DeGroote, MPH

  Epidemiologist
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• AF

  Ann Falsey, MD

  Dr
  University of Rochester
  Rochester, NY

  Disclosure: Gilead: Consultant, Grant/Research Support
  Janssen Pharmaceutical: Consultant
  Merck Sharpe and Dome: Consultant, Grant/Research Support
  Moderna: Consultant
  Pfizer: Consultant, Grant/Research Support
  sanofi pasteur: Consultant
• CW

  Caitlin Wolf, BA

  Research Scientist
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• PY

  Peiying Ye, PhD

  Biologist
  National Institutes of Health
  Potomac, MD

  Disclosure: Nothing to disclose
• MB

  Mariana Baz, PhD

  CHU de Quebec
  Université Laval
  Quebec, QC, Canada

  Disclosure: Nothing to disclose
• CC

  Charisse Cummings, MPH

  Epidemiologist
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• JL

  Jennifer Logue, BS

  Research Scientist
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• MM

  Maura Manion, MD

  Staff Clinician
  Division of Clinical Research, NIAID
  Bethesda, MD

  Disclosure: Nothing to disclose
• WS

  William Sieling, MPH

  Research Assistant
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Merck Co., Inc.: Grant/Research Support
• JT

  Jacqueline Tate, PhD

  EPIDEMIOLOGIST
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• YA

  Yacine Abed, PhD

  CHU de Quebec
  Université Laval
  Quebec, QC, Canada

  Disclosure: Nothing to disclose
• IB

  Isaac Brownell, MD/PHD

  Head, Cutaneous Development and Carcinogenesis Section
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose
• 

  Janet Englund, MD

  Professor
  Seattle Children's Hospital/Univ. of Washington
  Seattle, Washington

  Disclosure: AstraZeneca: Grant/Research Support
  Chimerix: Grant/Research Support
  GlaxoSmithKline: Consultant, Grant/Research Support
  Meissa Vaccines: Consultant
  Merck: Grant/Research Support
  Novavax: Grant/Research Support
  Sanofi Pasteur: Consultant
• RH

  Rachel Herlihy, MD. MPH

  State Epidemiologist
  Colorado Department of Public Health and Environment
  Denver, Colorado

  Disclosure: Nothing to disclose
• MO

  Matthew Oberhardt, PhD

  Program Director for Research Science
  NewYork-Presbyterian Hospital
  New York, NY

  Disclosure: Merck Co., Inc.: Grant/Research Support
• 

  Michael Boeckh, MD PhD

  Member
  Fred Hutchinson Cancer Research Center
  Seattle, Washington

  Disclosure: Ablynx: Consultant, Grant/Research Support
  Ansun Biopharma: Consultant, Grant/Research Support
  Astellas: Consultant, Grant/Research Support
  Bavarian Nordic: Consultant
  Chimerix: Consultant, Grant/Research Support
  Gilead: Consultant, Grant/Research Support
  GlaxoSmithKline: Consultant
  Helocyte: Consultant
  Janssen: Consultant, Grant/Research Support
  Lophius: Grant/Research Support
  Merck: Consultant, Grant/Research Support
  Moderna: Consultant
  Shire: Consultant, Grant/Research Support
  Vir Bio: Consultant, Grant/Research Support
• IS

  Irini Sereti, M.D.

  Chief, HIV Pathogenesis Section
  Laboratory of Immunoregulation, NIAID
  Bethesda, MD

  Disclosure: Nothing to disclose
• KY

  Kim Yousey-Hindes, MPH, CPH

  Epidemiologist 3
  Connecticut Emerging Infections Program
  New Haven, Connecticut

  Disclosure: Nothing to disclose
• 

  Philip Zachariah, MD, MSc

  Assistant Professor of Pediatrics/ Hospital Epidemiologist
  Columbia University Irving Medical Center/ NewYork Presbyterian Hospital
  New York, NY

  Disclosure: Nothing to disclose
• EA

  Evan Anderson, MD

  Infectious Diseases Physician
  Emory University, Atlanta VA Medical Center
  Atlanta, Georgia

  Disclosure: AbbVie: Consultant
  MedImmune: Scientific Research Study Investigator
  Merck: Scientific Research Study Investigator
  Micron Biomedical: Scientific Research Study Investigator
  Novavax: Grant/Research Support
  PaxVax: Scientific Research Study Investigator
  Pfizer: Grant/Research Support, Advisor or Review Panel member
  Regeneron: Scientific Research Study Investigator
  Sanofi Pasteur: Scientific Research Study Investigator
• 

  Helen Chu, MD MPH

  Assistant Professor
  University of Washington
  Seattle, WA

  Disclosure: Merck: Advisory Board
  Sanofi Pasteur: Research Grant
• WG

  William Greendyke, MD

  Assistant Professor of Medicine
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Nothing to disclose
• AL

  Andrea Lisco, MD/PHD

  Associate Clinical Investigator
  National Institute of Allergy and Infectious Diseases
  Washington, DC

  Disclosure: Nothing to disclose
• AB

  Angela Barrett, BA

  Research Coordinator
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Merck Co., Inc.: Grant/Research Support
• MM

  Maya Monroe, MPH

  Epidemiologist
  Maryland Department of Health and Mental Hygiene
  Baltimore, Maryland

  Disclosure: Nothing to disclose
• SK

  Sue Kim, MPH

  Epidemiologist
  Michigan Department of Health and Human Services
  Lansing, Michigan

  Disclosure: Nothing to disclose
• CV

  Celibell Vargas, MD

  Research Coordinator
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Merck Co., Inc.: Grant/Research Support
• LA

  Luis Alba, B.S.

  Research Assistant
  Columbia University Irving Medical Center
  New York, NY

  Disclosure: Nothing to disclose
• 

  Ruth Lynfield, MD

  State Epidemiologist
  Minnesota Department of Health
  St. Paul, Minnesota

  Disclosure: Nothing to disclose
• LI

  Lourdes Irizarry, MD

  Infectious Diseases Physician
  New Mexico Department of Health
  Santa Fe, NM

  Disclosure: Nothing to disclose
• MP

  Matthew Phillips, MPH

  Study Manager
  Merck & Co., Inc.
  North Wales, PA

  Disclosure: Merck Co., Inc.: Employee
• LF

  Lyn Finelli, DrPH, MS

  Director, Vaccines
  Merck & Co., Inc.
  Kenilworth, NJ

  Disclosure: Merck&Co.: Employee
• NS

  Nancy Spina, MPH

  Epidemiologist
  New York State Department of Health
  Albany, NY

  Disclosure: Nothing to disclose
• NB

  Nancy Bennett, MD

  Professor of Medicine and Public Health Sciences
  University of Rochester School of Medicine and Dentistry
  Rochester, NY

  Disclosure: Nothing to disclose
• MH

  Mary Hill, MPH

  Epidemiology Supervisor
  Salt Lake County Health Department
  Salt Lake City, UT

  Disclosure: Nothing to disclose
• CR

  Carrie Reed, DSc, MPH

  Epidemiologist
  CDC
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• WS

  William Schaffner, MD

  Director of Preventive Medicine
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Nothing to disclose
• KT

  Keipp Talbot, MD, MPH

  Infectious Diseases Physician
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Sanofi Pasteur: Grant/Research Support
  Sequirus: Advisor or Review Panel member
• WS

  Wesley Self, MD, MPH

  Associate Professor of Emergency Medicine
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• DW

  Derek Williams, MD, MPH

  Associate Professor of Pediatrics
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Nora Oliver, MD, MPH

  Assistant Professor
  Emory University
  Atlanta, GA

  Disclosure: Nothing to disclose
• 

  Sankar Swaminathan, MD, MS

  Division Chief
  Infections Diseases Division/Department of Medicine/University of Utah School of Medicine
  Salt Lake City, UT

  Disclosure: Nothing to disclose

Presenting Author(s)

• GB

  Guy Boivin, MD

  MD
  Centre Hospitalier Universitaire de Québec, Québec, Québec
  Quebec, QC, Canada

  Disclosure: BioCryst: Grant/Research Support
  Shionogi: Grant/Research Support
• AB

  Angela Branche, MD

  Assistant Professor of Medicine
  University of Rochester
  Rochester, NY

  Disclosure: GSK: Consultant
  Mercke Dohme and Sharpe: Consultant, Grant/Research Support
  Pfizer: Grant/Research Support
• JD

  Joshua Doyle, MD, PhD

  Epidemic Intelligence Service Officer
  Centers for Disease Control and Prevention
  Decatur, GA

  Disclosure: Nothing to disclose
• AE

  Anne Emanuels, MPH

  Research Scientist
  University of Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• BH

  Benjamin Hallowell, PhD, MPH

  Epidemic Intelligence Service Officer
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• HM

  Harry Mystakelis, MD

  Post-Doctoral Fellow
  National Institute of Allergy and Infectious Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose